BACKGROUND: Colorectal cancer (CRC) is the second most common cancer in Germany. Screening colonoscopies have been offered in Germany since 2002. However, validation of screening programs for CRC relies on estimates up to date. OBJECTIVE: The aim of this study was to analyze the influence of the risk factor tumor-suspicious symptoms on the prevalence of CRC and its precursor lesions in patients at least 55 years of age undergoing colonoscopy in comparison with an age-matched and sex-matched control population undergoing screening colonoscopy. DESIGN: Multicenter, prospective, controlled colonoscopy study. SETTING: Integrated care program of 49 gastroenterological practices in collaboration with a health insurance company and the screening colonoscopy program in Hesse, Germany. PATIENTS: In total, 1075 symptomatic and 5375 asymptomatic participants were matched for age and sex (1 : 5) from 1 October 2008 to 30 September 2010. MAIN OUTCOME MEASUREMENTS: Detection of CRC and its precursor lesions. RESULTS: Overall, the prevalence of CRC was significantly equivalent in both the symptomatic (n=13/1075, 1.21%) and the control group [n=55/5375, 1.02%, 95% confidence interval (CI) for the difference: [-0.46%, 0.83%], P=0.0002, equivalence test with δ=1.5%], respectively. Advanced adenomas were observed in significantly fewer symptomatic patients (61/1075, 5.67%) compared with 432/5375 matched asymptomatic screening participants (8.03%, 95% CI for the difference: [-3.98%, -0.74%], P=0.0094, difference test). Finally, polyps were found significantly less often in symptomatic patients (n=269/1075, 25.0%) than in matched screening participants (n=1807/5375, 33.6%, 95% CI for the difference: [-11.53%, -5.66%], P<0.0001, difference test). CONCLUSION: The results underline the importance of screening the symptom-free population at least 55 years of age to prevent CRC.
BACKGROUND:Colorectal cancer (CRC) is the second most common cancer in Germany. Screening colonoscopies have been offered in Germany since 2002. However, validation of screening programs for CRC relies on estimates up to date. OBJECTIVE: The aim of this study was to analyze the influence of the risk factor tumor-suspicious symptoms on the prevalence of CRC and its precursor lesions in patients at least 55 years of age undergoing colonoscopy in comparison with an age-matched and sex-matched control population undergoing screening colonoscopy. DESIGN: Multicenter, prospective, controlled colonoscopy study. SETTING: Integrated care program of 49 gastroenterological practices in collaboration with a health insurance company and the screening colonoscopy program in Hesse, Germany. PATIENTS: In total, 1075 symptomatic and 5375 asymptomatic participants were matched for age and sex (1 : 5) from 1 October 2008 to 30 September 2010. MAIN OUTCOME MEASUREMENTS: Detection of CRC and its precursor lesions. RESULTS: Overall, the prevalence of CRC was significantly equivalent in both the symptomatic (n=13/1075, 1.21%) and the control group [n=55/5375, 1.02%, 95% confidence interval (CI) for the difference: [-0.46%, 0.83%], P=0.0002, equivalence test with δ=1.5%], respectively. Advanced adenomas were observed in significantly fewer symptomatic patients (61/1075, 5.67%) compared with 432/5375 matched asymptomatic screening participants (8.03%, 95% CI for the difference: [-3.98%, -0.74%], P=0.0094, difference test). Finally, polyps were found significantly less often in symptomatic patients (n=269/1075, 25.0%) than in matched screening participants (n=1807/5375, 33.6%, 95% CI for the difference: [-11.53%, -5.66%], P<0.0001, difference test). CONCLUSION: The results underline the importance of screening the symptom-free population at least 55 years of age to prevent CRC.
Authors: Shadi A Esfahani; Pedram Heidari; Melanie H Kucherlapati; Jorge M Ferrer; Raju S Kucherlapati; Umar Mahmood Journal: Am J Nucl Med Mol Imaging Date: 2019-10-15
Authors: Ehud Segal; Tyler R Prestwood; Wouter A van der Linden; Yaron Carmi; Nupur Bhattacharya; Nimali Withana; Martijn Verdoes; Aida Habtezion; Edgar G Engleman; Matthew Bogyo Journal: Chem Biol Date: 2015-01-08
Authors: Olusegun Isaac Alatise; Omobolaji O Ayandipo; Ademola Adeyeye; Ken Seier; Akinwunmi O Komolafe; Matthew O Bojuwoye; Oludapo O Afuwape; Ann Zauber; Adeleye Omisore; Samuel Olatoke; Adegboyega Akere; Olusola Famurewa; Mithat Gonen; David O Irabor; T Peter Kingham Journal: Cancer Date: 2018-04-12 Impact factor: 6.860
Authors: Luis Bujanda; Cristina Sarasqueta; Pablo Vega; María Salve; Enrique Quintero; Victoria Alvarez-Sánchez; Fernando Fernández-Bañares; Jaume Boadas; Rafel Campo; Ana Garayoa; Angel Ferrandez; Leyanira Torrealba; Daniel Rodríguez-Alcaide; Mauro D'Amato; Vicent Hernández; Joaquin Cubiella Journal: United European Gastroenterol J Date: 2017-04-21 Impact factor: 4.623
Authors: Katharina Stratmann; Katarzyna Czerwinska; Natalie Filmann; Wolfgang Tacke; Christoph Weber; Herbert Bock; Irina Blumenstein Journal: Int J Colorectal Dis Date: 2021-03-05 Impact factor: 2.571